Indian equities posted their steepest weekly fall in seven months as the Sensex and Nifty extended losses amid U.S. visa curbs and drug tariffs. Pharma and IT stocks dragged, while FIIs stayed cautious. Analysts flagged key support at 24,500, with volatility expected around monthly expiry and global uncertainties weighing on sentiment.
Sebi board meeting: PMS rules overhaul, FPI commodity trades among key decisions to watch out
Sebi’s upcoming board meeting aims to discuss significant changes to portfolio management services and settlement regulations. Proposed revisions could allow discretionary portfolio managers to make